Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
Ginkgo Bioworks
DNA
$528M
| $333K | ﹤0.01% |
22,864
-1,331,753
| -98% | -$15.9M |
|
5177
Vivid Seats
SEAT
$84.6M
| $330K | ﹤0.01% |
19,863
+12,615
| +174% | +$297K |
|
5178
PUT
Booz Allen Hamilton
BAH
$8.39B
| $330K | ﹤0.01% |
+3,300
| New | +$353K |
|
|
GTENW
5179
CALL
Gores Holdings X Warrants
GTENW
$6.96M
| $329K | ﹤0.01% |
432,715
+78,000
| +22% | +$64.1K |
|
|
PRTC
5180
DELISTED
PureTech Health
PRTC
| $328K | ﹤0.01% |
17,841
-6,016
| -25% | -$106K |
|
5181
eGain
EGAN
$187M
| $328K | ﹤0.01% |
+37,695
| New | +$262K |
|
|
REE
5182
DELISTED
REE Automotive
REE
| $328K | ﹤0.01% |
463,899
+3,943
| +0.9% | +$2.79K |
|
5183
Ironwood Pharmaceuticals
IRWD
$696M
| $328K | ﹤0.01% |
250,119
+153,787
| +160% | +$159K |
|
5184
Schwab US Dividend Equity ETF
SCHD
$103B
| $325K | ﹤0.01% |
+11,913
| New | +$325K |
|
5185
PUT
Dropbox
DBX
$7.6B
| $323K | ﹤0.01% |
10,700
-3,800
| -26% | -$109K |
|
|
NOTE
5186
DELISTED
FiscalNote
NOTE
| $323K | ﹤0.01% |
69,762
-20,240
| -22% | -$131K |
|
5187
State Street SPDR S&P Bank ETF
KBE
$1.64B
| $323K | ﹤0.01% |
5,431
-10,416
| -66% | -$614K |
|
5188
Carter Bankshares
CARE
$766M
| $322K | ﹤0.01% |
16,598
+5,385
| +48% | +$100K |
|
5189
iShares MSCI South Korea ETF
EWY
$21.9B
| $320K | ﹤0.01% |
3,997
-48,109
| -92% | -$3.58M |
|
|
KDKRW
5190
CALL
Kodiak AI Warrants
KDKRW
| $320K | ﹤0.01% |
300,000
+75,000
| +33% | +$97.8K |
|
5191
Wingstop
WING
$3.53B
| $318K | ﹤0.01% |
1,265
-9,924
| -89% | -$3.08M |
|
5192
Norwood Financial Corp
NWFL
$370M
| $318K | ﹤0.01% |
12,507
+4,742
| +61% | +$121K |
|
5193
ZTO Express
ZTO
$18.3B
| $317K | ﹤0.01% |
16,536
-113,464
| -87% | -$2.17M |
|
5194
Nuveen Multi-Asset Income Fund
NMAI
$468M
| $317K | ﹤0.01% |
24,409
+3,000
| +14% | +$38K |
|
|
AVR
5195
Anteris Technologies
AVR
$763M
| $317K | ﹤0.01% |
70,380
-8,616
| -11% | -$33.8K |
|
|
SNDK
5196
CALL
Sandisk
SNDK
$180B
| $314K | ﹤0.01% |
+2,800
| New | +$164K |
|
|
SNDK
5197
PUT
Sandisk
SNDK
$180B
| $314K | ﹤0.01% |
+2,800
| New | +$164K |
|
|
CCIIW
5198
CALL
Cohen Circle Acquisition Corp II Warrant
CCIIW
$4.68M
| $314K | ﹤0.01% |
+330,145
| New | +$248K |
|
5199
Brown-Forman Class A
BF.A
$13.4B
| $313K | ﹤0.01% |
+11,646
| New | +$338K |
|
5200
Heron Therapeutics
HRTX
$93.9M
| $313K | ﹤0.01% |
248,503
-243,834
| -50% | -$387K |
|
Similar funds
Millennium Management's Q3 2025 Portfolio in Review
As of Q3 2025, Millennium Management held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Millennium Management added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Millennium Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Millennium Management fully exited Hess in Q3 2025, selling an estimated $478M.
- Millennium Management's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Millennium Management opened 800 new positions and closed 633 in Q3 2025.
- Millennium Management's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.